These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30389671)

  • 21. Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study.
    Mathieson L; Severn A; Guthrie B
    Scott Med J; 2013 May; 58(2):69-76. PubMed ID: 23728750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin Prescribing Patterns: An Analysis of Data From Patients With Diabetes in the National Hospital Ambulatory Medical Care Survey Outpatient Department and National Ambulatory Medical Care Survey Databases, 2005-2010.
    Pauff BR; Jiroutek MR; Holland MA; Sutton BS
    Clin Ther; 2015 Jun; 37(6):1329-39. PubMed ID: 25869626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the uses of aspirin, statins and ACEIs/ARBs in a diabetes outpatient population in southern Thailand.
    Pongwecharak J; Maila-ead C; Sakulthap J; Sripanitkulchai N
    J Eval Clin Pract; 2007 Apr; 13(2):221-6. PubMed ID: 17378868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality.
    Henke PK; Blackburn S; Proctor MC; Stevens J; Mukherjee D; Rajagopalin S; Upchurch GR; Stanley JC; Eagle KA
    J Vasc Surg; 2004 Feb; 39(2):357-65. PubMed ID: 14743136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeat prescriptions of guideline-based secondary prevention medication in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care.
    Kasteleyn MJ; Wezendonk A; Vos RC; Numans ME; Jansen H; Rutten GE
    Fam Pract; 2014 Dec; 31(6):688-93. PubMed ID: 25106412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK.
    Cea-Soriano L; Fowkes FGR; Johansson S; Allum AM; García Rodriguez LA
    BMJ Open; 2018 Jan; 8(1):e018184. PubMed ID: 29358428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of a Guideline to Decrease Use of Acid-Suppressing Medications in the NICU.
    Angelidou A; Bell K; Gupta M; Tropea Leeman K; Hansen A
    Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29162657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
    Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin inhibition after myocardial infarction: does drug class matter?
    Winkelmayer WC; Fischer MA; Schneeweiss S; Levin R; Avorn J
    J Gen Intern Med; 2006 Dec; 21(12):1242-7. PubMed ID: 17105523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Different Pharmacotherapies on Long-Term Outcomes in Patients with Electrical Storm.
    Schupp T; Behnes M; Ellguth D; Müller J; Reiser L; Bollow A; Taton G; Reichelt T; Engelke N; Kim SH; Nienaber C; Akin M; Mashayekhi K; Bertsch T; Borggrefe M; Akin I
    Pharmacology; 2019; 103(3-4):179-188. PubMed ID: 30695778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
    Myles PR; Hubbard RB; McKeever TM; Pogson Z; Smith CJ; Gibson JE
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):269-75. PubMed ID: 19235776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-Centre Study on Cardiovascular Risk Management on Patients Undergoing AAA Surveillance.
    Saratzis A; Dattani N; Brown A; Shalhoub J; Bosanquet D; Sidloff D; Stather P;
    Eur J Vasc Endovasc Surg; 2017 Jul; 54(1):116-122. PubMed ID: 28554728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
    Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
    J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome.
    González López-Valcárcel B; Librero J; García-Sempere A; Peña LM; Bauer S; Puig-Junoy J; Oliva J; Peiró S; Sanfélix-Gimeno G
    Heart; 2017 Jul; 103(14):1082-1088. PubMed ID: 28249992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin prescription among patients with type 2 diabetes in Botswana: findings and implications.
    Mwita JC; Godman B; Esterhuizen TM
    BMC Endocr Disord; 2020 Mar; 20(1):36. PubMed ID: 32151249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients.
    Choudhry NK; Setoguchi S; Levin R; Winkelmayer WC; Shrank WH
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1189-96. PubMed ID: 18956426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study.
    Ivers NM; Schwalm JD; Jackevicius CA; Guo H; Tu JV; Natarajan M
    Can J Cardiol; 2013 Nov; 29(11):1408-14. PubMed ID: 23816280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.